Atlas Trials

The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin Therapy

Clinical trial NCT06818851 · RECRUITING

Trial details

NCT number
NCT06818851
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2025-07-14
Primary completion
2027-12-31
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.